High remnant cholesterol and atherosclerotic cardiovascular disease in healthy women and men aged 70–100

医学 动脉粥样硬化性心血管疾病 疾病 低密度脂蛋白胆固醇 胆固醇 内科学 心脏病学
作者
Julie Riis,Børge G. Nordestgaard,Shoaib Afzal
出处
期刊:European Journal of Preventive Cardiology [Oxford University Press]
卷期号:32 (13): 1169-1177 被引量:6
标识
DOI:10.1093/eurjpc/zwaf092
摘要

Abstract Aims High remnant cholesterol has been increasingly recognized as an important risk factor for atherosclerotic cardiovascular disease (ASCVD). However, uncertainty remains regarding this association in old age. The aim of this study was to test the hypothesis that higher remnant cholesterol is associated with higher incidence of ASCVD in healthy women and men aged 70–100. Methods and results A total of 90,875 women (57%) and men aged 20–100 and without ASCVD, diabetes, or lipid-lowering therapy at baseline were included in the Copenhagen General Population Study in 2003–15. During a median follow-up of 12.8 years, 7352 were diagnosed with ASCVD. Incidence rates and hazard ratios were calculated according to age and sex. The highest incidence rate of ASCVD was observed in individuals aged 70–100 with a remnant cholesterol level >1.0 mmol/L (>39 mg/dL) [23 per 1000 person-years; 95% confidence interval (CI): 21–25]. Likewise, incidence rates of ASCVD per 1.0 mmol/L (39 mg/dL) higher remnant cholesterol were highest in individuals aged 70–100. Multivariable adjusted hazard ratio for 1.0 mmol/L (39 mg/dL) higher remnant cholesterol was 1.31 (95% CI: 1.20–1.44) in those aged 70–100, which was comparable with hazard ratios in younger age groups. Similar relationships were observed for women and men separately. Conclusion Higher remnant cholesterol was associated with higher incidence of ASCVD in those aged 70–100. The present results suggest that while relative rates of ASCVD for high vs. low remnant cholesterol do not increase with higher age, elevated remnant cholesterol contribute substantially to the absolute risk of ASCVD at age 70–100.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
伶舟行完成签到,获得积分10
1秒前
fan完成签到,获得积分20
1秒前
隐形的凡阳应助小狗蛋采纳,获得20
1秒前
HeatherMI完成签到 ,获得积分10
1秒前
某某完成签到,获得积分10
1秒前
顺利的向南完成签到,获得积分10
1秒前
realfsj发布了新的文献求助10
2秒前
2秒前
可爱的函函应助研友_Zrlk7L采纳,获得10
2秒前
何鸿成发布了新的文献求助10
3秒前
3秒前
FJ发布了新的文献求助10
3秒前
3秒前
菜鸟发布了新的文献求助10
4秒前
anjin发布了新的文献求助10
4秒前
外向寄云发布了新的文献求助10
4秒前
atun完成签到,获得积分10
4秒前
希望天下0贩的0应助小白采纳,获得10
5秒前
5秒前
iFreedom完成签到,获得积分10
5秒前
Ode完成签到,获得积分10
5秒前
优雅的雪一完成签到,获得积分10
6秒前
Owen应助brick2024采纳,获得10
6秒前
6秒前
戴迪完成签到,获得积分10
6秒前
www完成签到,获得积分10
6秒前
瑾风阳完成签到,获得积分10
6秒前
7秒前
无极微光应助cui采纳,获得20
7秒前
个性的饼干完成签到,获得积分10
7秒前
Orange应助研友_Z33zkZ采纳,获得10
7秒前
Chao完成签到,获得积分10
7秒前
liu完成签到,获得积分10
7秒前
7秒前
要吃虾饺完成签到,获得积分20
7秒前
vvvvv发布了新的文献求助10
7秒前
orixero应助紫焰采纳,获得10
7秒前
量子星尘发布了新的文献求助10
7秒前
7秒前
好运历险记完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Modified letrozole versus GnRH antagonist protocols in ovarian aging women for IVF: An Open-Label, Multicenter, Randomized Controlled Trial 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6062548
求助须知:如何正确求助?哪些是违规求助? 7894713
关于积分的说明 16310666
捐赠科研通 5205881
什么是DOI,文献DOI怎么找? 2785030
邀请新用户注册赠送积分活动 1767645
关于科研通互助平台的介绍 1647422